Clinical Trials Logo

Persian Gulf Syndrome clinical trials

View clinical trials related to Persian Gulf Syndrome.

Filter by:

NCT ID: NCT03560830 Completed - Gulf War Syndrome Clinical Trials

START & STOPP in GWI

START
Start date: February 2016
Phase:
Study type: Observational

Gulf War Illness (GWI) veterans were divided into 2 pathophysiological groups based on their orthostatic tachycardia responses after submaximal exercise. Two thirds had normal increases of 10 to 15 beats per minute between recumbent and standing both before and after exercise. These were termed the Stress Test Originated Phantom Perception (STOPP) phenotype. In contrast, one third had increases in heart rate of more than 30 beats per minute indicating that exercise induced postural tachycardia; there were the Stress Test Activated Reversible Tachycardia (START) group. This study aimed to confirm the original findings of Rayhan (2013).

NCT ID: NCT03547869 Terminated - Gulf War Syndrome Clinical Trials

Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.

Start date: March 12, 2018
Phase: N/A
Study type: Interventional

The goal of this study is to investigate long-term modulation of pain pathways leading to a suppression of pain symptoms in Gulf War Illness patients by applying transcranial direct current stimulation.

NCT ID: NCT03342482 Completed - Gulf War Syndrome Clinical Trials

Glutamate Neuro-Excitotoxicity in GWI

GWI
Start date: November 14, 2017
Phase: N/A
Study type: Interventional

The objective of the proposed research is to examine whether dietary exposure to food additives containing glutamate may be contributing to symptoms in Gulf War Illness (GWI). The rationale for proposed study comes from data in the fibromyalgia field which suggests that reducing the consumption of dietary glutamate can reduce over-excitation in the nervous system, leading to symptom improvement. In prior research, a low-glutamate diet (restricting food additive consumption) was tested in fibromyalgia patients. After one-month on the diet, 84% of patients had >30% of their symptoms go away (with 11 symptoms remitting on average), and 8 subjects had complete remission of all symptoms. Subjects then had a significant return of symptoms upon challenge with monosodium glutamate (MSG) as compared to placebo. Since there is almost complete symptom overlap between fibromyalgia and GWI, it is of utmost importance to test this diet as a low-cost treatment option in GWI patients. The findings from this research will ultimately be applicable to all GWI patients and potentially to other veterans with a similar symptom profile as well. The ultimate impact of this research could be quite profound, as it has the potential to impact all of the symptoms of GWI, as opposed to being a proposed treatment for only one of the symptoms. This dietary treatment has been shown to dramatically affect symptoms like fatigue, cognitive dysfunction, and pain; and thus, has the potential to dramatically improve quality of life for these individuals. Potential benefits of the treatment are great, and risks are minimal, as the treatment involves shifting the diet to a healthier, whole-food approach. First, the study will confirm or negate the idea that abnormal glutamate signaling in the nervous system could be causing symptoms in GWI. Second, if found to be successful, then this will provide a low-cost, easy-to-implement treatment option for the many veterans suffering from this multi-symptom illness. Third, this research could lead to future studies to identify potential causes of this abnormal neurotransmission, to help prevent future illness onset.

NCT ID: NCT03030794 Completed - Headache Clinical Trials

Alleviating Headache and Pain in GWI With Neuronavigation Guided rTMS

Start date: December 2016
Phase: N/A
Study type: Interventional

This study aims to assess the effect of repetitive transcranial magnetic stimulation (rTMS) on Gulf War illness related headaches and pain.

NCT ID: NCT02848417 Recruiting - Gulf War Syndrome Clinical Trials

Glutathione vs. Curcumin Clinical Trial

Glutathione
Start date: April 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The investigator proposes to perform a phase I/II study comparing two nutraceuticals and placebo that target mediators identified in the investigator's prior dynamic modeling study of Gulf War Illness (GWI). The investigator will repeat the dynamic modeling before treatment and on therapy to assess the modeling and the impact of the interventions on the homeostatic networks that have identified, with an added focus on the glutathione/redox system.

NCT ID: NCT02804828 Completed - Gulf War Syndrome Clinical Trials

Mitochondrial Cocktail for Gulf War Illness

Start date: April 9, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to develop preliminary evidence, such as effect size and variance estimates, to guide successful conduct of a properly-powered clinical trial to assess the benefit of a mitochondrial cocktail (incorporating individualization of treatment) in Gulf War illness (GWI).

NCT ID: NCT02075489 Completed - Clinical trials for Chronic Fatigue Syndrome

Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans

Start date: September 2012
Phase: N/A
Study type: Interventional

This study will provide symptomatic veterans with acupressure treatment and determine its effectiveness in fatigue relief and pain management for Gulf War Illness (GWI). Investigators plan to recruit patients reporting symptoms of GWI through the Department of Veterans Affairs (VA), and randomize them into acupressure group (to receive acupressure treatment) and control group (to receive Reiki treatment). The acupressure treatment, twice per week for 6 weeks, will be offered by a licensed acupressure practitioner. Evaluations will be made before and after treatment (at 6 weeks). Clinical outcomes will be compared between groups (acupressure group vs. control group) and between different timepoints (before treatment vs. after treatment) within the same group. The results of this study may provide useful information to develop more effective treatment for veterans with GWI disease. Since acupressure treatment is of Asian origin and has shown excellent promise within its Eastern traditions, if successful, this study has the potential to produce a paradigm shift in clinical practice to more effectively relieve the symptoms of veterans with GWI disease. Meanwhile, as a non-invasive therapeutic massage, acupressure may lend to better patient acceptance and ultimately, greater clinical accessibility. Hypotheses 1. Acupressure besides routine clinical care will produce a more complete fatigue relief and pain alleviation in veterans with GWI versus routine clinical care plus reiki treatment. 2. EEG measures will exhibit a positive change when fatigue is relieved and pain is alleviated for symptomatic veterans after effective treatment.

NCT ID: NCT01703767 Withdrawn - Clinical trials for Persian Gulf War Syndrome in Veteran

Gulf War 1 Veteran Healthcare Satisfaction

Start date: October 2014
Phase: N/A
Study type: Observational

The purpose of this study is to investigate Gulf War 1 Veteran (GW1V) patient perceptions of, and satisfaction with, their VA primary care treatment, and physician effectiveness in delivering improved point of service, in the Primary Care Clinics at the Veterans Administration (VA) Salt Lake City Health Care System.

NCT ID: NCT01700725 Completed - Fatigue Clinical Trials

Gulf War Illness Nasal Irrigation Study

GWINIS
Start date: October 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether nasal irrigation with Xylitol or saline are effective in the treatment of chronic rhinosinusitis and fatigue symptoms associated with Gulf War Illness.

NCT ID: NCT01543997 Completed - Sleep Disturbance Clinical Trials

Clinical Benefits of a Novel Sleep-focused Mind-body Program on Gulf War Illness (GWI) Symptoms

Start date: January 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate clinical benefits of a novel sleep-focused mind-body program on Gulf War Illness (GWI) symptoms.